Correction to: Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice (Targeted Oncology, (2021), 16, 5, (601-611), 10.1007/s11523-021-00826-1)

Adam Brufsky, Xianchen Liu, Benjamin Li, Lynn McRoy, Rachel M. Layman

Research output: Contribution to journalComment/debatepeer-review

Abstract

A peer-reviewed Plain Language Summary was retrospectively added to this publication.

Original languageEnglish (US)
Pages (from-to)865
Number of pages1
JournalTargeted oncology
Volume16
Issue number6
DOIs
StatePublished - Nov 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Correction to: Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice (Targeted Oncology, (2021), 16, 5, (601-611), 10.1007/s11523-021-00826-1)'. Together they form a unique fingerprint.

Cite this